Market Record Run Top and Bottom Portfolio Stocks Over Six Weeks Brainbees Solutions Narrows Q4 Loss as Firstcry Parent Reports 12 Revenue Growth Delivery Hero Shares Jump on Uber Takeover Offer at 33 Per Share Burberry Shares Climb on Speculation of Potential Moncler Takeover Bid Adani Group Companies Rally Recouping 150 Billion in Market Value PostHindenburg Phillips Connect Appoints Mark Wallin as President and General Manager Immunic Q1 2026 Earnings EPS Miss but Stock Surges 6 as Clinical Progress May Lift Sentiment BCE Q1 2026 Earnings EPS Beats Estimates by 825 Stock Rises DSGR Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower aTyr Pharma Q1 2026 Earnings NarrowerThanExpected Loss Provides Some Relief Amid Pipeline Development EZRA Q1 2023 Earnings Record EPS Surges on NonRecurring Gains Revenue Details Lacking TRTX Q1 2026 Earnings EPS Slightly Below Estimates Stock Edges Higher VirTra Inc VTSI Declines 187 as Shares Test Key Support Level NeoVolta Inc Warrant NEOVW Holds at 122 as Traders Eye Key Levels Lumexa Imaging Holdings LMRI Slides 22 as Support Levels Come Into Focus Tilray Brands TLRY Rises 225 as Cannabis Sector Shows Renewed Momentum Ally Financial ALLY Holds Steady Near 43 as Volume Signals Cautious Optimism Trump Seeks Supreme Court Intervention to Delay TikTok Ban Market Watches Regulatory Crossroads ANF Q1 2026 Earnings EPS Beat by 20 as Cost Discipline Drives Profitability First Citizens BancShares Preferred Series C FCNCO Preferred Stock Holds Steady Near 212 Amid Minimal Volatility Root Inc ROOT Q1 2026 Earnings EPS Surges Past Estimates by 1436 Shares Dip Slightly IHG Q4 2025 Earnings EPS Misses Estimates Amid Modest Stock Uptick ZION Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher CelSci Corporation CVM Q4 2024 Earnings Narrower Loss Beats Estimates Stock Slips Telus TU Q1 2026 Earnings Solid EPS Beat Amidst Steady Operational Execution Red River Bancshares Inc Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Lantheus Holdings LNTH Q1 2026 Earnings EPS Surges Past Estimates as Radiopharmaceutical Momentum Continues